NDC Labeler Janssen Biotech, Inc.

Janssen Biotech, Inc. labeler's code is 57894. The labeler has 18 products that have an assigned National Drug Code.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Product Type Status
57894-030Remicade InfliximabInjection, Powder, Lyophilized, For SolutionIntravenousHuman Prescription DrugACTIVE
57894-054Stelara UstekinumabSolutionIntravenousHuman Prescription DrugACTIVE
57894-060Stelara UstekinumabInjection, SolutionSubcutaneousHuman Prescription DrugACTIVE
57894-061Stelara UstekinumabInjection, SolutionSubcutaneousHuman Prescription DrugACTIVE
57894-070Simponi GolimumabInjection, SolutionSubcutaneousHuman Prescription DrugACTIVE
57894-071Simponi GolimumabInjection, SolutionSubcutaneousHuman Prescription DrugACTIVE
57894-111Carvykti Ciltacabtagene AutoleucelInjection, SuspensionIntravenousCellular TherapyACTIVE
57894-150Zytiga Abiraterone AcetateTabletOralHuman Prescription DrugACTIVE
57894-160Infliximab InfliximabInjection, Powder, Lyophilized, For SolutionIntravenousHuman Prescription DrugACTIVE
57894-195Zytiga Abiraterone AcetateTablet, Film CoatedOralHuman Prescription DrugACTIVE
57894-350Simponi Aria GolimumabSolutionIntravenousHuman Prescription DrugACTIVE
57894-449Tecvayli TeclistamabInjectionSubcutaneousHuman Prescription DrugACTIVE
57894-450Tecvayli TeclistamabInjectionSubcutaneousHuman Prescription DrugACTIVE
57894-501Rybrevant AmivantamabInjectionIntravenousHuman Prescription DrugACTIVE
57894-502Darzalex DaratumumabInjection, Solution, ConcentrateIntravenousHuman Prescription DrugACTIVE
57894-503Darzalex Faspro Daratumumab And Hyaluronidase-fihj (human Recombinant)InjectionSubcutaneousHuman Prescription DrugACTIVE
57894-505Darzalex Iv DaratumumabInjection, Solution, ConcentrateIntravenousHuman Prescription DrugACTIVE
57894-640Tremfya GuselkumabInjectionSubcutaneousHuman Prescription DrugACTIVE